Log in
Enquire now
‌

US Patent 11839660 Anti-transferrin receptor antibody and uses thereof

Patent 11839660 was granted and assigned to Dyne Therapeutics on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Dyne Therapeutics
Dyne Therapeutics
0
Current Assignee
Dyne Therapeutics
Dyne Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118396600
Patent Inventor Names
Brendan Quinn0
Cody A. Desjardins0
Mohammed T. Qatanani0
Romesh R. Subramanian0
Timothy Weeden0
John Najim0
Date of Patent
December 12, 2023
0
Patent Application Number
181817950
Date Filed
March 10, 2023
0
Patent Citations
‌
US Patent 9222940 Fused cyclooctyne compounds and their use in metal-free click reactions
0
‌
US Patent 7064142 Imidazonline compounds
0
‌
US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents
0
‌
US Patent 7575886 Analysis of sulfated polysaccharides
0
‌
US Patent 8859629 Fused cyclooctyne compounds and their use in metal-free click reactions
0
‌
US Patent 8952147 Conjugates, preparation thereof, and therapeutic use thereof
0
‌
US Patent 9504758 Modified antibody, antibody-conjugate and process for the preparation thereof
0
‌
US Patent 9550834 Method for preparing glycan-hydrolyzed antibody, and homogeneous glycosylated antibody
0
...
Patent Citations Received
‌
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
‌
US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
0
‌
US Patent 11969475 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
0
‌
US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 11931421 Muscle targeting complexes and formulations for treating myotonic dystrophy
0
‌
US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy
0
Patent Primary Examiner
‌
Aurora M Fontainhas
0
CPC Code
‌
A61K 2039/505
0
‌
A61K 47/6811
0
‌
A61K 47/6849
0
Patent abstract

Aspects of the disclosure relate to antibodies that bind to transferrin receptor (e.g., transferrin receptor 1) and complexes comprising the antibody covalently linked to a molecular payload. Methods of using the antibodies are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11839660 Anti-transferrin receptor antibody and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us